Literature DB >> 24854365

[Disseminated histoplasmosis treated by boluses of fluconazole].

C Mandengue Ebenye1, B Takuefou Mfangam2, C Nouédoui2, P J A Atangana3.   

Abstract

We report a case in which an HIV-infected man was cured of disseminated histoplasmosis (Histoplasma capsulatum var duboisii) after treatment by high-dose fluconazole (1,600 mg taken four times daily) for 2 months, combined with active antiretroviral therapy. The choice of fluconazole at this dosage was motivated by its availability as a generic and thus inexpensive medication, the patient's precarious status, and his critical clinical condition. At the end of the second month of treatment, the patient chose to stop the fluconazole, which he could no longer afford, while continuing the antiretroviral treatment, which was free. The clinical and laboratory improvement observed from the first week has continued to progress for more than 8 months after fluconazole treatment stopped. This single case needs - and deserves - to be confirmed in a series of patients. Nonetheless it makes it possible to envision fluconazole as a low-cost and efficacious antifungal agent for the treatment of disseminated histoplasmosis in AIDS patients in sub-Saharan Africa.

Entities:  

Keywords:  AIDS; Cameroon; disseminated histoplasmosis; fluconazole

Mesh:

Substances:

Year:  2015        PMID: 24854365     DOI: 10.1684/mst.2014.0332

Source DB:  PubMed          Journal:  Med Sante Trop        ISSN: 2261-3684


  2 in total

Review 1.  Histoplasmosis in Africa: Current perspectives, knowledge gaps, and research priorities.

Authors:  Bright K Ocansey; Chris Kosmidis; Martin Agyei; Améyo M Dorkenoo; Olusola O Ayanlowo; Rita O Oladele; Tchin Darre; David W Denning
Journal:  PLoS Negl Trop Dis       Date:  2022-02-24

2.  A Case of Histoplasmosis with Central Nervous System Relapse after Itraconazole Therapy Needs Further Research.

Authors:  Prashanth Peddi; Tejo Challa; Sreenath Meegada; Madhavi Annakula; Evan Mar
Journal:  Cureus       Date:  2020-02-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.